REG - Inspiration Health - Post Period Trading Update and Notice of Results

Inspiration HealthcareAnnouncement

17/02/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220217:nRSQ9297Ba&default-theme=true

RNS Number : 9297B  Inspiration Healthcare Group PLC  17 February 2022

Inspiration Healthcare Group plc

 ("Inspiration Healthcare", the "Company" or the "Group")

 

 

Post Period Trading Update and Notice of Results

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, is pleased to announce that, following the close of the financial
year, the Group is expecting to exceed market expectations and to report Group
revenues for the financial year ended 31 January 2022 of approximately £41.0
million representing an increase of 10.9% compared to the prior financial
year. Adjusted EBITDA(*) is expected to be not less than £6.2 million,
representing growth of 10.5% over the prior financial year, which includes a
one-off receipt of £0.2 million. Operating profit is similarly ahead of
market expectations.

 

The Company will be announcing its results for the financial year ended 31
January 2022 on Wednesday 4 May 2022.

Neil Campbell, Chief Executive Officer, commented: "I am very pleased to
announce that the Group has performed exceptionally strongly in what was a
difficult trading environment with many new problems arising out of the
ongoing Covid-19 pandemic such as supply chain issues and cost increases.
The Group is now well integrated, demand for our products remains high around
the world and we enter our new financial year with confidence.

 

I'm also pleased to report that we remain on track for the completion of our
new manufacturing, tech support and R&D facility in Croydon which is
expected to become operational in April 2022. This new facility will integrate
many of our operations under one roof and has been designed to ensure an
ultra-low environmental impact with the building utilising the very latest in
energy saving technologies to achieve this."

 

* Earnings before interest, tax, depreciation, amortisation, share based
payments and non-trading items.

The information contained within this announcement is deemed to constitute
inside information as stipulated under the UK version of the EU Market Abuse
Regulation (2014/596) which is part of UK law by virtue of the European Union
(Withdrawal) Act 2018, as amended and supplemented from time to time. Upon the
publication of this announcement, this inside information is now considered to
be in the public domain.

Enquiries:

 

 Inspiration Healthcare Group plc                                 Tel: 01455 840555

 Neil Campbell, Chief Executive Officer

 Jon Ballard, Chief Financial Officer
 Nominated Adviser & Broker                                       Tel: 0207 397 8900

 Cenkos Securities plc

 Mark Connelly

 Stephen Keys
 Cadogan PR                                                       Tel: 07771 713608

 Alex Walters

 alex.walters@cadoganpr.com (mailto:alex.walters@cadoganpr.com)

 

 

 

About Inspiration Healthcare Group

 

www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk)

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in critical care & operating theatres. The Company provides
high-quality, innovative products to patients around the world which help to
improve patient outcomes, and it actively invests in innovative product
opportunities and disruptive technologies.

 

The Group currently consists of three companies: Inspiration Healthcare Ltd,
SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal
intensive care and operating theatre equipment around the work through a
network of distributors into over 75 countries.  Products range from highly
sophisticated capital equipment through to single use disposables all that can
help improve outcomes of extremely sick patients.

 

In the UK and Ireland the Group offers direct sales for most of its products
supported by Technical Service offering on site and return to base repair and
maintenance along with 24/7 emergency hire of equipment and long term lease
arrangements for its own brand products.  The Group also acts as a
distributor for 3(rd) party companies that wish to access the NHS using the
Group's sales and service expertise and knowledge of the NHS

 

The Group invests in growth through Research and Development holding numerous
patents on its technology and has strong links with academic Key Opinion
Leaders around the world and supports clinical research in the field of
neonatal intensive care.

 

Further information on Inspiration Healthcare Group plc can be seen at
www.inspirationhealthcaregroup.plc.uk
(http://www.inspirationhealthcaregroup.plc.uk)

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCDGGDDRXBDGDL